Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
04/15/2014 | CA2527759C Use of s1p |
04/15/2014 | CA2495498C Use of cgrp antagonist compounds for treatment of psoriasis |
04/15/2014 | CA2474457C Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
04/15/2014 | CA2436208C A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
04/15/2014 | CA2427643C Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
04/15/2014 | CA2328414C Methods for detecting and inhibiting angiogenesis |
04/10/2014 | WO2014055995A1 Multi-analyte assay |
04/10/2014 | WO2014055978A1 System and method for providing patient-specific dosing as a function of mathematical models |
04/10/2014 | WO2014055963A1 Methods and systems for microfluidics imaging and analysis |
04/10/2014 | WO2014055951A1 Optical sensor for analyte detection |
04/10/2014 | WO2014055849A1 Methods for diagnosing and prognosing placental dysfunction and pre-eclampsia |
04/10/2014 | WO2014055832A1 Methods and systems for using encapsulated microbubbles to process biological samples |
04/10/2014 | WO2014055756A1 Method for measuring atr inhibition mediated increases in dna damage |
04/10/2014 | WO2014055653A1 Recurrent mutation in mitogen-activated protein kinase kinase kinase 5 (map3k5) for diagnosing and treating melanoma |
04/10/2014 | WO2014055559A1 Microfluidic sensors with enhanced optical signals |
04/10/2014 | WO2014055515A1 Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
04/10/2014 | WO2014055398A1 Method for detecting an increased risk or incidence of colorectal cancer |
04/10/2014 | WO2014055174A1 Position location aided by chemical characteristic |
04/10/2014 | WO2014055121A1 Markers capable of distinguishing cell pluripotency and uses thereof |
04/10/2014 | WO2014055025A1 Method and kit for analyte determination at acidic conditions |
04/10/2014 | WO2014054959A1 Method for activating the proliferation of stem cells and increasing the resistance thereof to adverse effects |
04/10/2014 | WO2014054826A1 Method for predicting prognosis for drug therapy for breast cancer using expression level of mmicrorna 210 |
04/10/2014 | WO2014054729A1 Method for detecting marker for liver/biliary tract diseases |
04/10/2014 | WO2014054712A1 Method for measuring hemagglutinin from influenza virus |
04/10/2014 | WO2014054675A1 Method for detecting primary aldosteronism, and monoclonal antibody |
04/10/2014 | WO2014054656A1 Dust-reducing agent comprising multiple metal compound, water absorbent containing multiple metal compound and method for manufacturing same |
04/10/2014 | WO2014054601A1 Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent |
04/10/2014 | WO2014054389A1 Immunoassay method utilizing surface plasmon |
04/10/2014 | WO2014054269A1 Elastic wave element and elastic wave sensor using same |
04/10/2014 | WO2014054024A1 Method for determining the oxidizing power of plasma hydroperoxides |
04/10/2014 | WO2014054013A1 Methods for predicting and monitoring mucosal healing |
04/10/2014 | WO2014053996A2 Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
04/10/2014 | WO2014053909A1 Animal model for multiple myeloma |
04/10/2014 | WO2014053871A1 A method for screening a compound capable of inhibiting the notch1 transcriptional activity |
04/10/2014 | WO2014053845A1 Method for aiding diagnosis of alzheimer's disease |
04/10/2014 | WO2014053679A1 Method and system for determining the freshness of fish, based on the processing of ocular images, and computer program implementing the method |
04/10/2014 | WO2014053634A1 New neutralizing antibodies directed against hepatitis c virus |
04/10/2014 | WO2014053617A1 Mitochondrial toxicity test |
04/10/2014 | WO2014053615A1 Use of leptospira fainei serovar hurstbridge bacteria for diagnosing|leptospirosis |
04/10/2014 | WO2014053603A1 Morphine-6-glucuronide derivatives, immunogens and immunoassay |
04/10/2014 | WO2014053570A1 Cell culture toxicity assay using calcium-dependent fluorescence |
04/10/2014 | WO2014053564A1 Means and methods for diagnosing recurrence of prostate cancer after prostatectomy |
04/10/2014 | WO2014053502A1 A method for predicting the risk of getting cancer or diagnosing cancer in a female subject |
04/10/2014 | WO2014053501A1 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction |
04/10/2014 | WO2014053481A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza |
04/10/2014 | WO2014053479A1 Methods of specifically releasing a sub-group of objects |
04/10/2014 | WO2014053460A1 Method of modulating the degree of adipose tissue deposited intramuscularly |
04/10/2014 | WO2014053353A1 Device and method for analysing a measurement gas |
04/10/2014 | WO2014053237A1 Multilayer microfluidic device and assay method |
04/10/2014 | WO2014053236A1 Air particle-detection arrangement and system and method for detecting air particles in order to determine the local particle load in the air |
04/10/2014 | WO2014053229A1 Method for processing measured values from a nitrogen oxide sensor |
04/10/2014 | WO2014053110A2 Peptides for the treatment and early diagnosis of alzheimer's disease and other tauopathies |
04/10/2014 | WO2014053028A1 Method of and apparatus for determining the carbon content of soils |
04/10/2014 | WO2014028939A3 Targeting phosphofructokinase and its glycosylation form for cancer |
04/10/2014 | WO2014028862A9 Use of dna in circulating exosomes as a diagnostic marker for metastasic disease |
04/10/2014 | WO2014027196A3 Physical property modelling |
04/10/2014 | WO2014023808A3 Method for evaluating a cancer patient for propensity to respond to a therapy |
04/10/2014 | WO2014021715A3 Gender, viability and/or developmental stage determination of avian embryos in ovo |
04/10/2014 | WO2014004670A3 Electrochemical system and method thereof |
04/10/2014 | WO2013188437A3 Ex vivo methods to identify circulating drug metabolites with drug interaction potential |
04/10/2014 | WO2013182912A4 Method for the diagnosis, prognosis and treatment of lung cancer metastasis |
04/10/2014 | WO2013160335A3 Antigens and antigen combinations |
04/10/2014 | WO2013132089A4 A method for predicting the risk of getting cancer or diagnosing cancer in a female subject |
04/10/2014 | WO2013124482A9 Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family |
04/10/2014 | WO2013056211A8 Telomerase reverse transcriptase deficiency as diagnostic marker of myelodysplastic syndrome |
04/10/2014 | WO2013054331A8 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
04/10/2014 | WO2012141792A3 Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin |
04/10/2014 | WO2012109025A3 Breast cancer diagnosis using nipple discharge |
04/10/2014 | WO2012103450A3 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
04/10/2014 | WO2012097368A3 Her3 and her4 primers and probes for detecting her3 and her4 mrna expression |
04/10/2014 | WO2012092629A3 Methods, cells, and systems for incorporating non-canonical amino acids into proteins |
04/10/2014 | WO2012088298A3 Epigenomic markers of cancer metastasis |
04/10/2014 | WO2012088210A3 Methods and compositions for wound treatment |
04/10/2014 | WO2012083274A3 Methods for diagnosis, prognosis and methods of treatment |
04/10/2014 | WO2012078470A3 Methods of small molecule directed regeneration from pluripotent stem cells |
04/10/2014 | WO2012071481A3 Organelle bioelectrodes and methods of making and using the same |
04/10/2014 | WO2012058532A3 Methods and compositions for assessing and treating cancer |
04/10/2014 | US20140101785 Genetically encoded calcium indicators and methods of use |
04/10/2014 | US20140100812 Systems and methods for evaluating environmental aspects of shipping systems |
04/10/2014 | US20140100797 System and method for determining the production of wells |
04/10/2014 | US20140100791 Patient-based results display |
04/10/2014 | US20140100790 Information processing system using nucleotide sequence-related information |
04/10/2014 | US20140100787 Assay Analysis, Tracking and Reporting System (AATR) |
04/10/2014 | US20140100525 Sampling module device and method |
04/10/2014 | US20140100188 Phenotyping tumor-infiltrating leukocytes |
04/10/2014 | US20140100167 Assessment of cardiac health and thrombotic risk in a patient |
04/10/2014 | US20140100163 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
04/10/2014 | US20140100141 Compartementalized integrated biochips |
04/10/2014 | US20140100138 Mechanical stress response analysis of cells and tissues |
04/10/2014 | US20140100137 Markers for impaired bone fracture healing |
04/10/2014 | US20140100136 Isolation and characterization of pathogens |
04/10/2014 | US20140100132 Processes for detecting or quantifying more than one nucleic acid in a library |
04/10/2014 | US20140100131 Methods and Reagents for Target Isolation from a Sample |
04/10/2014 | US20140100130 Methods and Compositions for the Diagnosis of Ovarian Cancer |
04/10/2014 | US20140100128 Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease |
04/10/2014 | US20140100127 Liver cancer diagnosis marker and use thereof |
04/10/2014 | US20140100123 Microvessels, microparticles, and methods of manufacturing and using the same |
04/10/2014 | US20140099733 Methods of Detecting Antibodies Specific for Denatured HLA Antigents |
04/10/2014 | US20140099729 Methods and Apparatus for Artificial Olfaction |
04/10/2014 | US20140099724 Fluorescent detection of in vitro translated protein on a solid surface |